Tatiana Novobrantseva

Company: NextPoint Therapeutics | Verseau Therapeutics

Job title: Chief Scientific Officer

Seminars:

Reprogramming Macrophages for Therapeutic Benefits 3:30 pm

Describing the common biology underlying macrophage states across various cancer indications Highlighting targets for inducing desired macrophage reprogramming Mapping out the challenges associated with macrophage plasticityRead more

day: Conference Day One

Industry Leader’s Fireside Chat: Contextualizing Macrophage-Specific Challenges in Comparison to Other Cell Types 8:20 am

Mapping out the potential of cell therapies by outlining incentives for focusing on macrophages Considering broad-perspective challenges to draw comparisons between working with macrophages and other cell types Understanding the advantages of macrophages to propel this form of cell therapyRead more

day: Conference Day One